Amulet Capital Partners completes acquisition of Genetics & IVF Institute to expand healthcare portfolio
Acquiring Company
Amulet Capital Partners
Acquired Company
Genetics & IVF Institute
GreenwichUnited StatesFinancial ServicesHealth CareNon ProfitBiotechnologyHealth CareDescription
Amulet Capital Partners, a middle-market private equity investment firm, has successfully acquired Genetics & IVF Institute (GIVF), a leading provider of reproductive tissue banking and related reproductive technology services. This strategic acquisition aims to support GIVF's next phase of growth and expansion to serve patients across the U.S. and abroad.
Quick answer
Amulet Capital Partners is acquiring Genetics & IVF Institute, announced September 6, 2024. Amulet Capital Partners is based in Greenwich, Connecticut, United States.
- How much did Amulet Capital Partners pay for Genetics & IVF Institute?
- The deal value was not disclosed.
- What does Amulet Capital Partners do?
- Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector.
- Where are Amulet Capital Partners and Genetics & IVF Institute based?
- Amulet Capital Partners is based in Greenwich, Connecticut, United States. Genetics & IVF Institute is based in United States.
- Who are the decision-makers at Amulet Capital Partners?
- Fundz holds 2 contacts at Amulet Capital Partners. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Non Profit
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Breeze Holdings Acquisition Corp. to merge with YD Biopharma Limited to revolutionize cancer prevention diagnostics (September 25, 2024)
- Rural Healthcare Group to acquire Steward Medical Group and Steward Health Care Network to expand access to high-quality care (August 14, 2024)
- AscellaHealth completes strategic acquisition of CHAPPER healthcare to expand global specialty pharmaceutical wholesale and product distribution services (October 17, 2024)
- Lupin strengthens its presence in the South African market through the acquisition of nine leading brands (October 4, 2024)
- Merck completes acquisition of investigational B-Cell depletion therapy, CN201, from Curon Biopharmaceutical (October 1, 2024)
- Valerio Therapeutics S.A. acquires Emglev Therapeutics to advance next-generation antibody-based therapeutics (September 30, 2024)
Who to call at Amulet Capital Partners, and when
When Amulet Capital Partners changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Amulet Capital Partners raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amulet Capital Partners, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amulet Capital Partners. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amulet Capital Partners makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Genetics & IVF Institute?
Genetics & IVF Institute was acquired by Amulet Capital Partners, based in Greenwich. The deal was reported on September 6, 2024. Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet Capital Partners is privately held and operates in Financial Services.
When did Amulet Capital Partners acquire Genetics & IVF Institute?
Amulet Capital Partners's acquisition of Genetics & IVF Institute was reported on September 6, 2024. Amulet Capital Partners, a middle-market private equity investment firm, has successfully acquired Genetics & IVF Institute (GIVF), a leading provider of reproductive tissue banking and related reproductive technology services. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Genetics & IVF Institute do?
Genetics & IVF Institute (GIVF) is a leading provider of reproductive tissue banking and related reproductive technology services. It is privately held, operating in Biotechnology, and is based in United States.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.